Results 121 to 130 of about 27,191 (241)

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

JEADV Clinical Practice, Volume 5, Issue 2, Page 385-393, June 2026.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson, Kara Hurley, Hannah Chaudhury, Lara Shehadeh, Cameron West   +4 more
wiley   +1 more source

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis

Haematologica, 2013
Valentina Poletto, Laura Villani, Paolo Catarsi, Rita Campanelli, Margherita Massa, Alessandro M. Vannucchi, Vittorio Rosti, Giovanni Barosi   +7 more
doaj   +1 more source

Adult TWIST2‐high B‐ALL confirms metabolic association but reveals molecular heterogeneity

HemaSphere, Volume 10, Issue 6, June 2026.
Wencke Walter, Veronika Ecker, Wolfgang Kern, Anna Stengel   +3 more
wiley   +1 more source

On‐Scanner Correction of Gradient Nonlinearity Bias for Accurate Assessment of Diffusion Heterogeneity Across Bone Sites in Myelofibrosis Patients

Magnetic Resonance in Medicine, Volume 95, Issue 6, Page 3386-3395, June 2026.
ABSTRACT Purpose To improve accuracy of apparent diffusion coefficient (ADC) measurement across different bone‐marrow (BM) sites for myelofibrosis (MF) patients. Methods Vendor‐provided ADC gradient nonlinearity correction (GNC) was implemented for 41 MF study subjects on a 3T clinical scanner.
Dariya Malyarenko, Brian D. Ross, Johannes M. Peeters, Ajit Devaraj, Ramin Jafari, Humera Tariq, Kristen M. Pettit, Moshe Talpaz, Gary D. Luker, Thomas L. Chenevert   +9 more
wiley   +1 more source

Myelofibrosis and True Histiocytic Lymphoma

, 1985
A 60-year-old female presented with a history of progressive shortness of breath, fever, and weight loss of 55 pounds. The work-up consisting of computerized axial tomography (CT) scan of thorax and abdomen, mediastinoscopy, and bilateral bone marrow ...
Ila Shah-Reddy, Latha Subramanian, Sudha Narang   +2 more
core   +1 more source

Secondary Pulmonary Alveolar Proteinosis Associated With Ruxolitinib After Bone‐Marrow Transplantation: A Case With Transient Improvement Following Drug Discontinuation

Respirology Case Reports, Volume 14, Issue 6, June 2026.
Secondary pulmonary alveolar proteinosis (PAP) may occur in patients receiving ruxolitinib for steroid‐refractory GVHD after bone marrow transplantation. In this case, a 47‐year‐old woman developed respiratory failure 8 months after commencing ruxolitinib therapy, and initial radiological and clinical improvements occurred after drug withdrawal, prior ...
Taiki Yanagi, Maki Asami‐Noyama, Kaoru Yamamoto, Yoshinobu Hoshii, Yasushi Ichiyama, Masatoshi Okimura, Tetsuya Fujii, Junki Suizu, Misa Harada, Keita Murakawa, Kazuki Hamada, Toshiaki Utsunomiya, Yoriyuki Murata, Keiji Oishi, Nobutaka Edakuni, Tomoyuki Kakugawa, Tsunahiko Hirano, Kazuto Matsunaga   +17 more
wiley   +1 more source

On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases

Small, Volume 22, Issue 33, 12 June 2026.
The deformability of red blood cell is essential for smooth microcirculation. We propose a deformability index using a microfluidic platform with capillary‐like constrictions, based on the relationship between cell deformation and transit velocity through the constrictions. Its effectiveness and clinical potential have been demonstrated in applications
Kenji Kajitani, Chia‐Hung Dylan Tsai, Tomohito Ohtani, Shigeo Wada, Ivan Cimrák, Misato Chimura, Tatsunori Taniguchi, Yasutaka Ueda, Jun‐ichi Nishimura, Yasushi Sakata   +9 more
wiley   +1 more source

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country

British Journal of Haematology, Volume 208, Issue 6, Page 2036-2046, June 2026.
The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Eric Oksenhendler, Marion Malphettes, Véronique Meignin, David Boutboul, Lionel Galicier   +4 more
wiley   +1 more source

Hepatic nodule: a case of primary myelofibrosis

, 2012
Primary myelofibrosis is one of the entities that may manifest with lesions of extramedullary haematopoiesis, especially in spleen and liver. The authors report a case of primary myelofibrosis presenting incidentally as an intrahepatic focal lesion of ...
Pires, J, Miranda, J, Cardoso, F, Araújo, JM   +3 more
core   +1 more source

Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study

European Journal of Haematology, Volume 116, Issue 6, Page 850-862, June 2026.
ABSTRACT Background Individuals with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) face transformation risks to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). While older age is linked to increased risk, it remains unclear whether risk increases with age or with disease duration.
Nurgul Batyrbekova, Anna Ravn Landtblom, Malin Hultcrantz, Robert Szulkin, Paul W. Dickman, Therese M.‐L. Andersson   +5 more
wiley   +1 more source